Gene Therapy- FDA and Local Considerations

Course Description

In this talk, which was presented to FDA, IRBs and study teams throughout the US, Kaitlin Morrison, PhD takes you through gene therapy trials and what you need to know about them beyond your typical IIT process. This includes insights into specific protocol requirements and additional review bodies that will oversee your study.

Learning Objectives

  • Learning how manufacturing limitations play into clinical operations.
  • Learning techniques to educate patients on complicated gene therapy concepts.
  • Learning techniques to succeed in gene therapy regulatory reviews.


Taking the Course

To continue, click the button Take Course.

If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at unclcn@unc.edu or (919) 445–1000.

Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
04/29/2022
Course expires: 
04/27/2026
Photo of Kaitlin Morrison, PhD 

Kaitlin Morrison, PhD

Director of UNC Lineberger Sponsored Clinical Research
Assistant Professor of Medicine, Division of Hematology

UNC Lineberger Sponsored Clinical Research
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

Presenter Disclosure Information

The presenter has no relevant financial relationships with ineligible companies as defined by the ACCME

 

 

The following accrediting agencies have approved this course for continuing education credits. Participants should understand that their individual participation and claiming credit must abide by the regulations set forth by their respective accrediting agency.

1.00 General Participation Credit
UNC Lineberger Cancer Network certificate of participation.

 

Available Credit

  • 1.00 Participation
Please login or register to take this course.